{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:46:44Z","timestamp":1759063604211},"reference-count":23,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["POR"],"DOI":"10.2147\/por.s364066","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T07:50:14Z","timestamp":1653637814000},"page":"33-41","source":"Crossref","is-referenced-by-count":6,"title":["Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India"],"prefix":"10.2147","volume":"Volume 13","author":[{"given":"Shashank","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agam","family":"Vora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod","family":"Dadhich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Daxini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiprasad","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanmant","family":"Barkate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,5]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. IHR emergency committee on novel coronavirus (2019-nCoV) [internet]. Available from: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov);. Accessed June 27, 2021."},{"key":"ref2","unstructured":"World Health Organization. Coronavirus (COVID-19) Dashboard [Internet]. Available from: https:\/\/covid19.who.int\/. Accessed April 25, 2022."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","volume":"102","author":"Joshi","year":"2021","journal-title":"Int J Infect Dis"},{"key":"ref4","unstructured":"Approval of favipiravir tablets to Glenmark Pharmaceuticals and Remdesivir Injection to Cipla Ltd, Hetero Drugs and Mylan Labs. Available from: https:\/\/cdsco.gov.in\/opencms\/opencms\/system\/modules\/CDSCO.WEB\/elements\/download_file_division.jsp?num_id=NjIxMw==;. Accessed June 16, 2021."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.eng.2020.03.007","volume":"10","author":"Cai","year":"2020","journal-title":"Engineering"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.17.20037432","volume":"03","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijid.2020.11.142","volume":"103","author":"Udwadia","year":"2021","journal-title":"Int J Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/14787210.2022.2012155","volume":"20","author":"Deng","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref9","unstructured":"Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial. Available from: https:\/\/www.principletrial.org\/news\/Favipiravir-to-be-investigated-as-a-possible-covid-19-treatment-for-at-home-recovery-in-the-principle-trial;. Accessed July 22, 2021."},{"key":"ref10","unstructured":"The prevent severe Covid-19 (PRESECO) study (PRESECO). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04600895;. Accessed July 22, 2021."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mjafi.2020.08.004","volume":"76","author":"Agrawal","year":"2020","journal-title":"Med J Armed Forces India"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01897-20","volume":"64","author":"Doi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"11022","DOI":"10.1038\/s41598-021-90551-6","volume":"11","author":"Hassanipour","year":"2021","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.cmi.2021.12.026","volume":"28","author":"Bosaeed","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s40121-021-00517-4","volume":"10","author":"Shinkai","year":"2021","journal-title":"Infect Dis Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12879-021-06164-x","volume":"21","author":"Manabe","year":"2021","journal-title":"BMC Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12985-020-01412-z","volume":"17","author":"Shrestha","year":"2020","journal-title":"Virol J"},{"key":"ref18","first-page":"100773","volume":"33","author":"Johnston","year":"2021","journal-title":"E Clinl Med"},{"key":"ref19","unstructured":"Mahumad R. Clinical trial of ivermectin plus doxycycline for the treatment of confirmed Covid-19 infection. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04523831;. Accessed June 25, 2021."},{"key":"ref20","first-page":"4","volume":"13","author":"Dheir","year":"2021","journal-title":"Konuralp Med J"},{"key":"ref21","first-page":"ciaa1176","volume":"73","author":"Ivashchenko","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijid.2020.11.191","volume":"103","author":"Ahmed","year":"2021","journal-title":"Int J Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S2055-6640(20)30016-9","volume":"6","author":"Pilkington","year":"2020","journal-title":"J Virus Erad"}],"container-title":["Pragmatic and Observational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=81091","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=81091","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T07:50:22Z","timestamp":1653637822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/real-world-experience-with-favipiravir-for-the-treatment-of-mild-to-mo-peer-reviewed-fulltext-article-POR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":23,"URL":"https:\/\/doi.org\/10.2147\/por.s364066","relation":{},"ISSN":["1179-7266"],"issn-type":[{"value":"1179-7266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}